Scientific Leadership

CURE OM Steering Committee

The CURE OM Scientific Steering Committee is responsible for providing guidance and expertise for the research and treatment aspects of the CURE OM initiative.

The CURE OM Scientific Steering Committee is an international, multidisciplinary team composed of scientists, researchers, and doctors that provides expert guidance on ocular melanoma science and helps shape the direction of future research into ocular melanoma.


Keith T. Flaherty, MD
Associate Professor of Medicine, Harvard Medical School
Director of Developmental Therapeutics
Massachusetts General Hospital Cancer Center, Boston, Massachusetts

J. William Harbour, MD
Professor and Vice Chairman of Opthalmology
Director, Ocular Oncology Service
Bascom Palmer Eye Institute
University of Miami School of Medicine Miami, Florida


Laurence Desjardins, MD
Head of Department Ophthalmic Oncology Service
Curie Institute
Paris, France

Elizabeth A. Grimm, PhD
Professor, Melanoma Medical Oncology
Deputy Division Head for Research, Division of Cancer Medicine
University of Texas, MD Anderson Cancer Center Houston, Texas

Hans E. Grossniklaus, MD
Professor of Ophthalmology and Pathology Director
Ocular Oncology and Pathology Service
Emory University School of Medicine Atlanta, Georgia

F. Stephen Hodi, Jr, MD
Director, Melanoma Disease Center
Associate Professor of Medicine
Dana-Farber Cancer Institute Harvard Medical School Boston, Massachusetts

Jacob Pe’er, MD
Professor and Chairman, Department of Ophthalmology
Jonas Friedenwald Professor of Ophthalmic Research
Hadassah Hebrew University Medical Center
Jerusalem, Israel

James F. Pingpank, Jr, MD, FACS
Associate Professor of Surgery, Division of Surgical Oncology
Hillman Cancer Center
University of Pittsburgh, Pittsburgh, Pennsylvania

Takami Sato, MD, PhD
K. Hasumi Professor of Medicine and Medical Oncology
Department of Medical Oncology
Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, Pennsylvania

Dirk Schadendorf, MD
Director and Chair, Department of Dermatology
University Hospital Essen
Essen, Germany

Sara M. Selig, MD
CURE OM Director, Melanoma Research Foundation
Department of Internal Medicine
Brigham and Women’s Hospital Boston, Massachusetts

Stefan Seregard, MD, PhD
Professor of Ophthalmology
Department of Clinical Neuroscience, Karolinska Institute
Chairman, Department of Vitreoretinal Diseases
St. Eriks Eye Hospital
Stockholm, Sweden

Carol L. Shields, MD
Co-Director Oncology Services
Wills Eye Institute Professor of Ophthalmology, Thomas Jefferson University Hospital
Philadelphia, Pennsylvania

Michael J. Weber, PhD
Professor of Microbiology and Weaver Professor of Oncology
Director, University of Virginia Cancer Center
University of Virginia Cancer Center
Charlottesville, Virginia

David J. Wilson, MD
Professor and Thiele-Petti Chair, Department of Ophthalmology
Director, Casey Eye Institute
Oregon Health and Science University Portland, Oregon